Tuesday, January 30, 2007

YAZ: Three Indications in One

BERLIN - The U.S. Food and Drug Administration has approved a new use of Bayer Schering Pharma AG's drug YAZ to allow it to be used to treat moderate acne in women who also want to use an oral contraceptive for birth control, the company said Monday.

With the approval, YAZ becomes the first oral contraceptive approved by the FDA for three distinct uses, Bayer said in a statement. In addition to being approved for birth control use and now for acne control, it is also approved to treat the emotional and physical symptoms of premenstrual dysphoric disorder.


(text links mine)

Labels: , ,

2 Comments:

At 1:23 AM, Blogger Sharon said...

My doctor told me just last week that evidence is mounting that Yaz contributes to osteoporosis. I'm assuming it's the drsp form of progesterone that's the culprit, which means Yasmin would be a problem too. Anyone heard about this?

 
At 1:35 AM, Blogger Sharon said...

Well, my new doctor must not be very well-informed. (sigh) Google has turned up studies claiming the opposite: combo bcp's with drsp work well to reduce bone loss.

 

Post a Comment

Links to this post:

Create a Link

<< Home